Skip to main content
    N

    Nexgel Inc (NXGL)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $3.93
    +0.05 (+1.29%)

    Market Cap: $2.08M

    Last updated: Nov 17, 2026 at 10:58 AM ET

    Nexgel Inc (NXGL) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Nexgel (NXGL) to earn -$18.80 per share in the fiscal year ending Dec 31, 2026, on revenue of $15.79M. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$4.40.

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 53.7%.

    Fiscal year ending Dec 31, 2026
    -$18.80
    EPS consensus, revenue $15.79M
    Fiscal year ending Dec 31, 2027
    -$4.40
    EPS consensus, revenue $24.27M
    Next report
    Mar 29, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$18.80-$18.80 to -$18.801$15.79M$15.79M to $15.79M1
    Dec 31, 2027-$4.40-$4.40 to -$4.401$24.27M$24.27M to $24.27M1

    Quarterly Estimates

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$4.08N/A3$5.37M$5.16M to $5.52M3

    Estimate Revisions

    Across the 2 periods below, the last 30 days brought 0 upward and 2 downward EPS revisions. Cuts outnumber raises in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202601
    Fiscal year ending Dec 31, 202701

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$2.40.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$18.80-$2.40-$2.40-$2.40-$2.40N/A
    Fiscal year ending Dec 31, 2027-$4.40$8.00$8.00$8.00$8.00N/A

    Frequently Asked Questions About NXGL

    What is the NXGL stock forecast?

    Consensus analyst estimates put Nexgel's EPS at -$18.80 for the fiscal year ending Dec 31, 2026, on revenue of $15.79M.

    What EPS do analysts expect from NXGL next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$18.80, with estimates from -$18.80 to -$18.80 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$4.40, with estimates from -$4.40 to -$4.40 from 1 analyst.

    What revenue do analysts expect from Nexgel next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $15.79M, with estimates from $15.79M to $15.79M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $24.27M, with estimates from $24.27M to $24.27M.

    How many analysts cover NXGL?

    1 analyst estimates EPS for Nexgel for the fiscal year ending Dec 31, 2026.